Lorenzo is the Co-Founder CEO&COO of GreenBone Ortho srl.
Lorenzo has a degree in Biological Sciences obtained at Università degli Studi di Milano with
a Ph.D. in Pharmacology. Lorenzo has more then 25 years experiences in R&D, Business
Development and Venture Capital. He worked in multinational mid size companies and large
corporations such as Zambon Group SpA and Cardinal Health Inc., now Catalent Inc. During
such period he established different collaborations with pharmaceutical and biotech companies
also based on pharmaceutical products and technologies like Drug Delivery Systems and
Medical Devices. General Manager of Zcube srl (Research Venture of Zambon Group) from
2008 leveraged to company to a global leader in translational medicine through collaborations
and investments with universities in Europe, United States and Israel, as well as with Mission
Bay Capital and the California Institute for Quantitative Biosciences (QB3), which is
headquartered on the UCSF Mission Bay campus. Part of the syndicate during SuppreMol
GmbH acquisition by Baxter International Inc. for EUR 200 million (March 4, 2015). Member
of ETPN Executive Board (European Technology Platform on Nanomedicine), President of
Italy HealthCare Licensing Group (ItalyHLG) 2010-2014 and Honorary President of the
Business Development Academy since 2014.